The Pharma Data

OCTOBER 21, 2020

21 October 2020 — ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical development programme.

Clinical Development 52

Clinical Development Therapies Clinical Trials FDA Approval 52

Drug Discovery World

JANUARY 12, 2023

Following the launch of Protas, DDW spoke with Protas Chief Executive, Professor Sir Martin Landray, who echoed Cooper’s emphasis on the importance of clinical trial design. DDW shared a global data analysis from Phesi, which showed the extent of the impact from the war in Ukraine on clinical development.

Clinical Trials 243

Clinical Trials Drugs Trials Pharmaceutical Companies 243

Drug Discovery World

MARCH 6, 2024

How precision neuroscience is benefiting pharmaceutical companies Even stratified, these subgroups are still huge markets – Alzheimer’s and other dementias are estimated to directly cost US health systems $345B per year and this will rise by 2050 to $1 trillion.

Clinical Trials 162

Clinical Trials Pharmaceutical Companies Disease Trials 162

Drug Discovery World

AUGUST 12, 2022

Pfizer has launched a Phase III clinical trial of a vaccine to protect people against Lyme disease, in collaboration with pharmaceutical company Valneva. . VLA15 is the only Lyme disease vaccine candidate currently in clinical development.

Vaccine 130

Vaccine Disease Trials Pharmaceutical Companies 130

PPD

MAY 7, 2024

Challenges and opportunities of the new EU HTA regulation The implementation of centralized HTA presents both opportunities and challenges for pharmaceutical companies. Particularly for small and mid-size pharmaceutical companies, meeting these timelines could be a significant hurdle.

Regulations 52

Regulations Pharmaceutical Companies International Pharmaceuticals 52

Drug Discovery World

MAY 6, 2024

In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. In 2022, the continent held a 22.4%

Drugs 147

Drugs Molecular Biology Science Clinical Trials 147

Advarra

APRIL 4, 2024

Continuity of Experience Imagine a pharmaceutical company is embarking on a series of clinical trials for a particular therapeutic area, such as oncology or neurology. This continuity of experience enables the DSMB to provide the pharmaceutical company with more nuanced and informed recommendations throughout the entire program.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Trials FDA Compliance 52

Drug Discovery World

MARCH 7, 2023

She currently leads the company’s pipeline of chronic disease immunotherapeutic candidates including for Alzheimer’s, Parkinson’s, and hypercholesterolemia, as well as variant-inclusive Covid-19 booster. She has been named to Time 100 Next list, Fortune 40 under 40, and is a member of the Young Global Leaders of World Economic Forum.

International 246

International Science Pharmaceuticals DNA 246

Drug Discovery World

NOVEMBER 18, 2022

The lack of financial incentive for pharmaceutical companies developing antibiotics means that many companies no longer focus their efforts on R&D for antimicrobials. The AMR Action Fund was launched in 2020 as the largest public-private partnership investing in antimicrobials.

Pharmaceutical Companies 130

Pharmaceutical Companies Government Pharmaceuticals Hospitals 130

Drug Discovery World

SEPTEMBER 14, 2023

Erdafitinib has demonstrated promising results in advanced, FGFR-altered UC, making this submission a vital step towards improving outcomes for patients in the future.

Treatment 130

Treatment Clinical Pharmacology FDA Approval Therapies 130

Drug Discovery World

AUGUST 10, 2023

Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialisation of cytisinicline. As such, the company has achieved some key milestones this year.

FDA Approval 130

FDA Approval Clinical Trials Drugs FDA 130

Drug Target Review

JULY 18, 2023

AI is being used to find the targets themselves, design the drugs to manipulate that biology, and thirdly, AI is being used to support validation of those targets and drugs as part of pre-clinical development. With support from pharmaceutical companies, ultimately, the answer to this question should be yes.

Drug Development 98

Drug Development Drugs Pharmaceutical Companies Clinical Development 98

Cytel

OCTOBER 11, 2023

Moving beyond static evidence development to ensure local market access success; responding to recent changes in governmental drug regulations and the role of automation Written by Grammati Sarri and Radek Wasiak The worldwide drug regulation landscape is rapidly changing.

Marketing 59

Marketing Pharmaceutical Companies Regulations Pharmaceuticals 59

Drug Discovery World

MARCH 5, 2024

Pharmaceutical companies now consider patients as true research partners, working towards a collective goal of progressive treatment and cure. SD : If we look across the current clinical development landscape, there are close to 100 interventional trials ongoing (epilepsy, recruiting and non-recruiting active, phase I-III).

Disease 147

Disease Treatment Research Pharmaceutical Companies 147

Drug Discovery World

AUGUST 8, 2022

DDW Editor Reece Armstrong speaks to Stephanie Seremetis, Chief Medical Officer, Rare Blood Disorders at Novo Nordisk to get her response to the company’s latest study results for its Mim8 antibody. We look forward to moving into phase 3 clinical development, which is due to commence in Q4 2022.

Treatment 130

Treatment Clinical Trials International Disease 130

Drug Discovery World

JULY 2, 2024

The centre currently has 58 pharma/biotech assets that are in pre-clinical development, alongside 29 that are being tested in clinical trials. In terms of fundraising, a number of start-ups based in the western region have obtained significant investment or been acquired by large pharmaceutical companies in recent years.

Science 147

Science Drugs Clinical Trials Licensing 147

Drug Target Review

JANUARY 8, 2024

Jerry has over 30 years of experience in the biopharmaceutical industry and has been involved in the discovery, clinical development, and global commercialisation of more than a dozen FDA-approved drugs with multiple successful exits. a commercial stage pharmaceutical company.

Science 145

Science Disease FDA Approval DNA 145

Conversations in Drug Development Trends

MAY 14, 2024

As the strategists for Worldwide Clinical Trials’ rare disease sponsors, we design customized solutions that make a difference in achieving successful outcomes. Our approach is informed by our combined 30+ years in rare disease clinical development and our time in various stakeholder roles, such as scientists, CRAs, and project managers.

Disease 81

Disease Clinical Trials Trials Pharmaceutical Companies 81

Cytel

MARCH 3, 2023

For one pharmaceutical company looking to evaluate the potential impact of surrogate endpoints on long-term clinical outcomes in multiple myeloma, an SLR was needed in just two months for the research to support reimbursement submissions. This gets compounded by obstacles to accessing the newest publications.

Research 52

Research Pharmaceutical Companies Pharmaceuticals Clinical Development 52

Cytel

DECEMBER 2, 2022

For 35 years , Cytel’s scientific rigor and operational excellence have enabled biotech and pharmaceutical companies to navigate uncertainty, prove value, and make evidence-based decisions with confidence.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Clinical Trials Clinical Development 52

Drug Discovery World

DECEMBER 22, 2022

McLendon provides executive leadership and oversight for ICON’s clinical and project management teams in the implementation and execution of vaccine and infectious disease clinical development programmes.

Vaccine 130

Vaccine Disease Clinical Trials Trials 130

Drug Discovery World

SEPTEMBER 14, 2023

As the second quarter of 2023 draws to a close, DDW’s Megan Thomas reviews key updates and results from three top pharmaceutical companies. joined Pfizer’s Executive Leadership Team as Chief Oncology Research and Development Officer and Executive Vice President reporting to Chairman and Chief Executive Officer, Albert Bourla.

Vaccine 147

Vaccine FDA Approval Drugs Licensing 147

Vial

APRIL 10, 2024

The increasing costs associated with in-house drug development have prompted biotech and pharmaceutical companies to increasingly outsource to contract research organization s (CROs) for assistance.

Clinical Trials 52

Clinical Trials Trials Compliance Clinical Research 52

Conversations in Drug Development Trends

MAY 14, 2024

As the strategists for Worldwide Clinical Trials’ rare disease sponsors, we design customized solutions that make a difference in achieving successful outcomes. Our approach is informed by our combined 30+ years in rare disease clinical development and our time in various stakeholder roles, such as scientists, CRAs, and project managers.

Disease 52

Disease Clinical Trials Trials Pharmaceutical Companies 52

The Pharma Data

JANUARY 4, 2021

for expanding activities in the US with its initial focus on facilitating clinical development. Outline of the new company (1) Company name: Meiji Pharma USA Inc. (2) Location: 500 Frank W. (6) Established: 4 July, 2020 (7) Shareholding structure: Wholly-owned by Meiji Seika Pharma Co.,

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceuticals Clinical Development Clinical Research 40

The Pharma Data

JANUARY 17, 2021

The companies announced in January 2019 a collaboration agreement to develop, manufacture and commercialize SPR206 in the Territory. SPR206 is in clinical development as an innovative option for the treatment of multi-drug resistant (MDR) Gram-negative bacterial infections. SHANGHAI , Jan.

Clinical Trials 52

Clinical Trials Clinical Development Pharmacokinetics Pharmaceutical Companies 52

The Pharma Data

JUNE 19, 2023

The findings bolster the idea, which is currently under investigation in at least three clinical trials, that when it comes to treating resistant breast cancer, two drugs may be better than one. A promising new frontier in cancer treatment The study, a collaboration with pharmaceutical company Pfizer Inc.,

Drugs 40

Drugs Pharmaceutical Companies Clinical Trials Clinical Development 40

PPD

DECEMBER 14, 2023

In this blog, we’ll explore the benefits associated with employing global resources across time zones for FSP engagements and how PPD ® FSP solutions utilize different regions to drive more efficient clinical development operations.

Clinical Development 52

Clinical Development Clinical Trials International Trials 52

Drug Target Review

FEBRUARY 1, 2024

In other cases, well-established biomarker profiles enable patient enrichment strategies in early-stage clinical development. We have been hard at work for two-and-a-half years on developing a precision treatment for GRIN-related disorders, a genetically defined developmental epileptic encephalopathy.

Therapies 104

Therapies Drug Development Disease Clinical Development 104

The Pharma Data

MARCH 29, 2022

“We believe in advancing health through partnerships and are excited to embark on this journey, strengthening our ability to create a positive impact on patient lives,” shared Uli Brödl, senior vice president, global clinical development and operations at Boehringer Ingelheim.

Therapies 52

Therapies Clinical Development Pharmaceutical Companies Research 52

Advarra

AUGUST 10, 2023

The Orphan Drug Act creates incentives for developing orphan drugs to treat such diseases. The FDA plans to launch Operation Warp Speed for Rare Diseases in 2023 with a focus on increased communication between the agency and drug and biotech companies. Keep in mind, there is no cost to register an IBC with the NIH.

Drug Development 52

Drug Development Disease Engineering Therapies 52

The Pharma Data

NOVEMBER 23, 2020

At Ultimovacs, he will lead all business and corporate development efforts and continue to maintain and foster connections with leading biotechnology and pharmaceutical companies. “In

Clinical Trials 52

Clinical Trials Small Molecule Pharmaceutical Companies Licensing 52

The Pharma Data

DECEMBER 31, 2020

where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. He also previously served as Global CMO at Taiho Pharmaceutical Company, Ltd. Benedetti most recently served as chief medical officer for Apollomics, Inc.,

Engineering 52

Engineering Pharmaceuticals Virus Clinical Development 52

The Pharma Data

OCTOBER 6, 2021

Janssen is now moving its dengue program into clinical development. We look forward to working with our collaborators to accelerate clinical development.”. “As Global Head of Global Public Health R&D at Janssen Research & Development, LLC. Janssen Pharmaceutica, N.V.

Virus 52

Virus Clinical Development Science Disease 52

Drug Discovery World

OCTOBER 30, 2023

Once novel targets have been discovered, understanding which patients will likely benefit from them, and using that to guide clinical trial design and recruitment is key to accelerating and de-risking their clinical development.

Treatment 182

Treatment Clinical Trials Disease Trials 182

Sygnature Discovery

JULY 31, 2023

Additionally, the company provides protein chemistry services and offers crucial knowledge-based expertise in structural biology at the initial stages of drug discovery to global biotech and pharmaceutical companies.

Computational Chemistry 52

Computational Chemistry Science Pharmaceutical Companies Clinical Trials 52

The Pharma Data

MARCH 1, 2022

We are excited to see how our technology and global biobank partnerships can transform research capabilities for Boehringer Ingelheim and deliver powerful impacts for clinical development pipelines across disease areas.”. “We Lifebit’s patented federated technology securely unlocks access to biomedical data.

Pharmaceutical Companies 52

Pharmaceutical Companies Disease Government Clinical Development 52